Insmed Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	20,964	37,289	12,385	4,586	2,710	3,234
Market Cap Growth	73.45%	201.09%	170.06%	69.20%	-16.20%	-5.45%
Enterprise Value	20,483	36,609	12,261	5,164	2,888	3,130
Last Close Price	96.72	174.04	69.04	30.99	19.98	27.24
PS Ratio	25.58	61.49	34.05	15.03	11.05	17.16
PB Ratio	29.71	50.46	43.40	-13.82	30.82	7.88
P/TBV Ratio	28.48	46.87	39.69	-13.11	27.95	7.44
EV/Sales Ratio	24.99	60.37	33.71	16.92	11.77	16.61
Debt / Equity Ratio	1.04	1.00	4.55	-4.06	14.98	1.47
Net Debt / Equity Ratio	-0.68	-0.92	-0.43	-1.74	2.02	-0.25
Net Debt / EBITDA Ratio	0.43	0.55	0.14	-0.83	-0.40	0.29
Net Debt / FCF Ratio	0.52	0.70	0.18	-1.05	-0.43	0.28
Asset Turnover	0.38	0.28	0.22	0.20	0.17	0.18
Inventory Turnover	1.13	1.07	0.94	0.86	0.81	0.76
Quick Ratio	3.88	3.35	4.99	3.64	6.19	5.48
Current Ratio	4.47	3.83	5.45	4.12	6.69	6.19
Return on Equity (ROE)	-163.97%	-249.28%	3926.49%	614.47%	-193.22%	-126.66%
Return on Assets (ROA)	-53.33%	-58.36%	-52.57%	-47.69%	-31.63%	-36.63%
Return on Invested Capital (ROIC)	-235.49%	-278.45%	-213.18%	-177.44%	-113.56%	-124.03%
Return on Capital Employed (ROCE)	-65.63%	-70.77%	-62.03%	-55.22%	-35.53%	-42.01%
Buyback Yield / Dilution	-20.64%	-21.32%	-16.81%	-14.14%	-9.74%	-14.86%
Total Shareholder Return	-20.64%	-21.32%	-16.81%	-14.14%	-9.74%	-14.86%

SEC Filings: 10-K · 10-Q